The fibrin sealants market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of recombinant and synthetic sealants, reliance on autologous and bovine-derived sealants, increasing surgical procedures, rising awareness about hemostasis, adoption of fibrin sealants in general surgeries.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.
The increasing number of cosmetic surgeries is increasingly supporting the expansion of the fibrin sealants market going forward. Cosmetic surgeries are medical procedures primarily performed to enhance or modify physical appearance. The growing volume of cosmetic surgeries is linked to societal emphasis on aesthetics, advancements in surgical techniques, and increased availability of minimally invasive procedures. Fibrin sealants assist cosmetic surgeries by promoting faster wound healing, minimizing bleeding, reducing scarring, and improving overall surgical outcomes and recovery. For example, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons organization, liposuction remained the most frequently performed cosmetic surgery in 2023 with 347,782 procedures, reflecting a 7% increase from 2022, while tummy tuck procedures rose by 5% to 170,110 cases. Consequently, the rising number of cosmetic surgeries is strengthening growth prospects for the fibrin sealants market.
Leading companies operating in the fibrin sealants market are focusing on developing innovative solutions, such as fibrin sealants, to improve hemostasis, reduce surgical complications, enhance wound healing, and support patient recovery. Fibrin sealants are biological adhesives derived from blood components that replicate the final steps of natural clot formation. For example, in October 2024, Grifols S.A., a Spain-based biopharmaceutical company, received FDA approval for its fibrin sealant for treating surgical bleeding in pediatric patients. The product supports precise hemostasis, reduces postoperative complications, and can be used across a variety of surgical settings.
In July 2024, Corza Medical, a US-based manufacturer of advanced surgical technologies, acquired Takeda’s TachoSil manufacturing operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to improve service levels and enhance global customer support. Takeda is a Japan-based pharmaceutical company involved in the development and production of fibrin sealants.
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc.
North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the fibrin sealants market by increasing the cost of imported raw materials and advanced production equipment, including recombinant protein production systems. Segments such as recombinant and synthetic sealants are particularly impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased production costs and potential delays in supply. On the positive side, tariffs encourage local production, investment in domestic manufacturing facilities, and innovation in cost-effective sealant solutions.
The fibrin sealants market research report is one of a series of new reports that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Fibrin sealants, also called fibrin glues or tissue adhesives, are medical products used to support blood clotting and promote tissue healing. Made from fibrinogen and thrombin - proteins involved in natural clot formation - they are commonly used in surgery to control bleeding in delicate areas where stitches or cauterization may not be sufficient.
The primary types in the fibrin sealants market include liquid, patch, and powder formulations. Liquid fibrin sealants contain fibrinogen and thrombin, which combine to form a fibrin clot when applied. These products are used during surgical procedures to control bleeding and enhance tissue bonding and can be administered through methods such as dripping or spraying for accurate placement. The technologies include autologous donation, viral inactivation, recombinant production, and others. The applications span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, transplant surgery, and others, and the end users include hospitals, ambulatory surgical centers, and other healthcare facilities.
The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.
The increasing number of cosmetic surgeries is increasingly supporting the expansion of the fibrin sealants market going forward. Cosmetic surgeries are medical procedures primarily performed to enhance or modify physical appearance. The growing volume of cosmetic surgeries is linked to societal emphasis on aesthetics, advancements in surgical techniques, and increased availability of minimally invasive procedures. Fibrin sealants assist cosmetic surgeries by promoting faster wound healing, minimizing bleeding, reducing scarring, and improving overall surgical outcomes and recovery. For example, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons organization, liposuction remained the most frequently performed cosmetic surgery in 2023 with 347,782 procedures, reflecting a 7% increase from 2022, while tummy tuck procedures rose by 5% to 170,110 cases. Consequently, the rising number of cosmetic surgeries is strengthening growth prospects for the fibrin sealants market.
Leading companies operating in the fibrin sealants market are focusing on developing innovative solutions, such as fibrin sealants, to improve hemostasis, reduce surgical complications, enhance wound healing, and support patient recovery. Fibrin sealants are biological adhesives derived from blood components that replicate the final steps of natural clot formation. For example, in October 2024, Grifols S.A., a Spain-based biopharmaceutical company, received FDA approval for its fibrin sealant for treating surgical bleeding in pediatric patients. The product supports precise hemostasis, reduces postoperative complications, and can be used across a variety of surgical settings.
In July 2024, Corza Medical, a US-based manufacturer of advanced surgical technologies, acquired Takeda’s TachoSil manufacturing operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to improve service levels and enhance global customer support. Takeda is a Japan-based pharmaceutical company involved in the development and production of fibrin sealants.
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc.
North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the fibrin sealants market by increasing the cost of imported raw materials and advanced production equipment, including recombinant protein production systems. Segments such as recombinant and synthetic sealants are particularly impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased production costs and potential delays in supply. On the positive side, tariffs encourage local production, investment in domestic manufacturing facilities, and innovation in cost-effective sealant solutions.
The fibrin sealants market research report is one of a series of new reports that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Fibrin sealants, also called fibrin glues or tissue adhesives, are medical products used to support blood clotting and promote tissue healing. Made from fibrinogen and thrombin - proteins involved in natural clot formation - they are commonly used in surgery to control bleeding in delicate areas where stitches or cauterization may not be sufficient.
The primary types in the fibrin sealants market include liquid, patch, and powder formulations. Liquid fibrin sealants contain fibrinogen and thrombin, which combine to form a fibrin clot when applied. These products are used during surgical procedures to control bleeding and enhance tissue bonding and can be administered through methods such as dripping or spraying for accurate placement. The technologies include autologous donation, viral inactivation, recombinant production, and others. The applications span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, transplant surgery, and others, and the end users include hospitals, ambulatory surgical centers, and other healthcare facilities.
The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Fibrin Sealants Market Characteristics
3. Fibrin Sealants Market Supply Chain Analysis
4. Global Fibrin Sealants Market Trends and Strategies
5. Fibrin Sealants Market Analysis of End Use Industries
7. Global Fibrin Sealants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Fibrin Sealants Total Addressable Market (TAM) Analysis for the Market
9. Fibrin Sealants Market Segmentation
10. Fibrin Sealants Market Regional and Country Analysis
11. Asia-Pacific Fibrin Sealants Market
12. China Fibrin Sealants Market
13. India Fibrin Sealants Market
14. Japan Fibrin Sealants Market
15. Australia Fibrin Sealants Market
16. Indonesia Fibrin Sealants Market
17. South Korea Fibrin Sealants Market
18. Taiwan Fibrin Sealants Market
19. South East Asia Fibrin Sealants Market
20. Western Europe Fibrin Sealants Market
21. UK Fibrin Sealants Market
22. Germany Fibrin Sealants Market
23. France Fibrin Sealants Market
24. Italy Fibrin Sealants Market
25. Spain Fibrin Sealants Market
26. Eastern Europe Fibrin Sealants Market
27. Russia Fibrin Sealants Market
28. North America Fibrin Sealants Market
29. USA Fibrin Sealants Market
30. Canada Fibrin Sealants Market
31. South America Fibrin Sealants Market
32. Brazil Fibrin Sealants Market
33. Middle East Fibrin Sealants Market
34. Africa Fibrin Sealants Market
36. Fibrin Sealants Market Competitive Landscape and Company Profiles
37. Fibrin Sealants Market Other Major and Innovative Companies
40. Fibrin Sealants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Fibrin Sealants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for fibrin sealants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fibrin sealants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Liquid; Patch; Powder2) By Technology: Autologous Donation; Viral Inactivation; Recombinant Production; Other Technologies
3) By Application: General Surgery; Cardiovascular Surgery; Wound Management; Orthopedic Surgery; Urological Surgeries; Ophthalmic Surgeries; Transplant Surgery; Other Applications
4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Liquid: Bovine-Derived Liquid Sealants; Human-Derived Liquid Sealants; Synthetic Liquid Sealants; Recombinant Fibrin Sealants2) By Patch: Bovine-Derived Fibrin Patches; Human-Derived Fibrin Patches; Synthetic Fibrin Patches; Bioabsorbable Fibrin Patches
3) By Powder: Bovine-Derived Fibrin Powder; Human-Derived Fibrin Powder; Synthetic Fibrin Powder; Recombinant Fibrin Powder
Companies Mentioned: Johnson & Johnson; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; CSL Behring; Grifols S.A.; Sigma-Aldrich; Nordson Corporation; Integra LifeSciences Corporation; Shanghai RAAS Blood Products Co. Ltd.; Mallinckrodt Pharmaceuticals; Biotest AG; LFB Group; Hualan Biological Engineering Inc.; Corza Medical; Aesculap Inc.; Ethicon Inc.; CryoLife Inc.; VIVEX Biologics Inc.; MediWound Ltd.; Cohesion Technologies Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Fibrin Sealants market report include:- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Asahi Kasei Medical Co. Ltd.
- Baxter International Inc.
- CSL Behring
- Grifols S.A.
- Sigma-Aldrich
- Nordson Corporation
- Integra LifeSciences Corporation
- Shanghai RAAS Blood Products Co. Ltd.
- Mallinckrodt Pharmaceuticals
- Biotest AG
- LFB Group
- Hualan Biological Engineering Inc.
- Corza Medical
- Aesculap Inc.
- Ethicon Inc.
- CryoLife Inc.
- VIVEX Biologics Inc.
- MediWound Ltd.
- Cohesion Technologies Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.27 Billion |
| Forecasted Market Value ( USD | $ 1.73 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
